{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T08:35:25Z","timestamp":1793435725346,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","award":["C2\\u20132023-3516"],"award-info":[{"award-number":["C2\\u20132023-3516"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["479591"],"award-info":[{"award-number":["479591"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","award":["20353"],"award-info":[{"award-number":["20353"]}],"id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cct.2026.108475","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:20:02Z","timestamp":1789453202000},"page":"108475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rationale and design of a clinical trial of a reduced dosing schedule for the nonavalent human papillomavirus vaccine in women living with HIV: The NOVA-HIV study"],"prefix":"10.1016","volume":"170","author":[{"given":"Emma","family":"Karlsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Boucoiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Brophy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Elwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hankins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Hornsberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mel","family":"Krajden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marette","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Loutfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Martel-Laferri\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina S.","family":"Ogilvie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Poliquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Sadarangani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Severini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Sivro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise","family":"Vachon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"van Schalkwyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Walmsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Yaphe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Yudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"McClymont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Money","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cct.2026.108475_bb0005","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.cct.2026.108475_bb0010","author":"Cancer CPA"},{"key":"10.1016\/j.cct.2026.108475_bb0015","series-title":"Cervical Cancer Causes, Risk Factors, and Prevention","author":"Institute NC","year":"2025"},{"issue":"1","key":"10.1016\/j.cct.2026.108475_bb0020","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/ijgo.13185","article-title":"Prevalent and persistent oncogenic HPV types in a cohort of women living with HIV prior to HPV vaccination","volume":"150","author":"McClymont","year":"2020","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"3","key":"10.1016\/j.cct.2026.108475_bb0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/QAI.0000000000002258","article-title":"Brief report: persistence of non-vaccine oncogenic HPV genotypes in quadrivalent HPV-vaccinated women living with HIV","volume":"83","author":"McClymont","year":"2020","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"4","key":"10.1016\/j.cct.2026.108475_bb0030","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/QAI.0b013e31828177d7","article-title":"Invasive cervical cancer risk among HIV-infected women: a north American multicohort collaboration prospective study","volume":"62","author":"Abraham","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.cct.2026.108475_bb0035","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ygyno.2006.06.015","article-title":"Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia","volume":"103","author":"Parham","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cct.2026.108475_bb0040","author":"World Health Organization"},{"issue":"10108","key":"10.1016\/j.cct.2026.108475_bb0045","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0140-6736(17)31821-4","article-title":"Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial","volume":"390","author":"Huh","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cct.2026.108475_bb0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.adaj.2019.10.010","article-title":"Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines: umbrella review of systematic reviews","volume":"151","author":"Villa","year":"2020","journal-title":"J. Am. Dent. Assoc."},{"issue":"3","key":"10.1016\/j.cct.2026.108475_bb0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40121-017-0166-x","article-title":"Vaccinations for the HIV-infected adult: a review of the current recommendations, Part I","volume":"6","author":"Crum-Cianflone","year":"2017","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.cct.2026.108475_bb0060","author":"World Health Organization"},{"key":"10.1016\/j.cct.2026.108475_bb0065","author":"World Health Organization"},{"key":"10.1016\/j.cct.2026.108475_bb0070","author":"World Health Organization"},{"issue":"3","key":"10.1016\/j.cct.2026.108475_bb0075","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007187","article-title":"The HIV-1 epidemic: low- to middle-income countries","volume":"2","author":"Shao","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.cct.2026.108475_bb0080","author":"Guidelines Review Committe, Sexual and Reproductive Health and Research (SRH)"},{"issue":"4","key":"10.1016\/j.cct.2026.108475_bb0085","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jogc.2023.02.012","article-title":"Acceptability and preferences of dry HR HPV self-sampling mailed kits among Canadian women: a cross-sectional study","volume":"45","author":"Ruel-Lalibert\u00e9","year":"2023","journal-title":"J. Obstet. Gynaecol. Can."},{"issue":"6","key":"10.1016\/j.cct.2026.108475_bb0090","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.3390\/curroncol29060308","article-title":"Willingness to self-collect a sample for HPV-based cervical Cancer screening in a well-screened cohort: HPV FOCAL survey results","volume":"29","author":"Lesack","year":"2022","journal-title":"Curr. Oncol."},{"issue":"3","key":"10.1016\/j.cct.2026.108475_bb0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/LGT.0000000000000476","article-title":"Acceptability of women self-sampling versus clinician-collected samples for HPV DNA testing: a systematic review","volume":"23","author":"Morgan","year":"2019","journal-title":"J. Low. Genit. Tract Dis."},{"issue":"8","key":"10.1016\/j.cct.2026.108475_bb0100","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4161\/hv.29205","article-title":"Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types","volume":"10","author":"Roberts","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"issue":"9","key":"10.1016\/j.cct.2026.108475_bb0105","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.3390\/curroncol31090399","article-title":"Self-screening for cervical Cancer offered through a digital platform in a region of British Columbia with lower screening rates","volume":"31","author":"Smith","year":"2024","journal-title":"Curr. Oncol."},{"issue":"2","key":"10.1016\/j.cct.2026.108475_bb0110","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/JCM.06090-11","article-title":"Novel microsphere-based method for detection and typing of 46 mucosal human papillomavirus types","volume":"50","author":"Zubach","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.cct.2026.108475_bb0115","author":"ICH Expert Working Group"},{"issue":"5","key":"10.1016\/j.cct.2026.108475_bb0120","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/S1470-2045(15)70075-6","article-title":"Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging","volume":"16","author":"Lowy","year":"2015","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.cct.2026.108475_bb0125","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1542\/peds.2014-3745","article-title":"Immunogenicity and safety of a 9-valent HPV vaccine","volume":"136","author":"Van Damme","year":"2015","journal-title":"Pediatrics"},{"issue":"17","key":"10.1016\/j.cct.2026.108475_bb0130","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.2013.1625","article-title":"Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial","volume":"309","author":"Dobson","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2026.108475_bb0135","author":"Government of Canada"},{"issue":"3","key":"10.1016\/j.cct.2026.108475_bb0140","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1093\/cid\/ciaa1897","article-title":"Immunogenicity and safety of the 9-valent human papillomavirus vaccine in solid organ transplant recipients and adults infected with human immunodeficiency virus (HIV)","volume":"73","author":"Boey","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cct.2026.108475_bb0145","article-title":"Immunogenicity and safety of two versus three doses of 9-valent vaccine against human papillomavirus (HPV) in women with HIV: the papillon randomized trial","author":"Konopnicki","year":"2025","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.cct.2026.108475_bb0150","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/cid\/ciy575","article-title":"The efficacy of the quadrivalent human papillomavirus vaccine in girls and women living with human immunodeficiency virus","volume":"68","author":"McClymont","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"40","key":"10.1016\/j.cct.2026.108475_bb0155","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1016\/j.vaccine.2016.08.016","article-title":"HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine","volume":"34","author":"Money","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.cct.2026.108475_bb0160","unstructured":"Government of Canada. Summary of NACI Statement of July 24, 2024: Updated Recommendations on Human Papillomavirus Vaccines 2024. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/vaccines-immunization\/national-advisory-committee-immunization-summary-updated-recommendations-hpv-vaccines.html."},{"key":"10.1016\/j.cct.2026.108475_bb0165","author":"British Columbia Pharmacy Association"},{"key":"10.1016\/j.cct.2026.108475_bb0170","author":"Government of Manitoba"},{"key":"10.1016\/j.cct.2026.108475_bb0175","author":"Gouvernement du Qu\u00e9bec"},{"key":"10.1016\/j.cct.2026.108475_bb0180","series-title":"Primary End-points for Prophylactic HPV Vaccine Trials","author":"IARC HPV Working Group","year":"2014"},{"issue":"15","key":"10.1016\/j.cct.2026.108475_bb0185","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1016\/j.vaccine.2020.02.075","article-title":"Impact of quadrivalent HPV vaccine dose spacing on immunologic response in women living with HIV","volume":"38","author":"McClymont","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.cct.2026.108475_bb0190","author":"BC Cancer"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714426002612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714426002612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T08:19:15Z","timestamp":1793434755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714426002612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":38,"alternative-id":["S1551714426002612"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2026.108475","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of a clinical trial of a reduced dosing schedule for the nonavalent human papillomavirus vaccine in women living with HIV: The NOVA-HIV study","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2026.108475","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108475"}}